Regulations

(bennymarty/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The US agency continues releasing resources, offering advice and taking actions related to the pandemic, and how life-sciences professionals respond.

(gilz/iStock via Getty Images Plus)

Weekly FDA COVID-19 updates and actions

By Jenni Spinner

The agency continues to offer advice to pharma industry professionals during the global public health crisis, and offer advice on developing solutions.

(Who_I_am/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The US agency continues to issue advice, offer guidance and take action related to the virus behind the global pandemic.

(rudal30/iStock via Getty Images Plus)

FDA COVID-19 updates for the week

By Jenni Spinner

The federal agency continues to aid drug developers, trial teams and the public with advice and actions related to the virus behind the global pandemic.

(Nuthawut Somsuk/iStock via Getty Images Plus)

Newest FDA actions and alerts on COVID-19

By Jenni Spinner

The federal agency continues to monitor as the virus impacts the pharma and clinical trials industries, offering advice and taking action where necessary.

(elenabs/iStock via Getty Images Plus)

Latest FDA COVID-19 updates

By Jenni Spinner

The federal agency continues to offer advice and take actions related to COVID-19, impacting drug development, clinical trials and other activities.

(zubada/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The agency continues to offer advice and take actions impacting the pharmaceutical and life-science industries during the pandemic.

(Image: Nanoform)

Nanoform granted GMP certification

By Jenni Spinner

The Finnish nanoparticle technology specialist’s facility has been given the stamp of approval by the Finnish Medicines Agency.

(Image: Getty/zubada)

This week's FDA COVID-19 actions and advice

By Jenni Spinner

The federal agency continues to offer advice for healthcare and pharma industry professionals, and to take action against companies acting out of bounds.

(Image: Getty/ffrikretow)

Weekly FDA COVID-19 update

By Jenni Spinner

The agency continues to remain busy overseeing and approving potential treatments and tests for the virus behind the global pandemic.